On October 11, 2021 Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that its Chief Executive Officer, Saiid Zarrabian, will present a corporate overview at the 14th Annual LD Micro Main Event Conference which is being held at the Luxe Sunset Bel-Air in Los Angeles from October 12 – 14, 2021 (Press release, Kintara Therapeutics, OCT 11, 2021, https://ir.kintara.com/news/detail/976/kintara-therapeutics-to-present-at-the-ld-micro-main-event-conference [SID1234591057]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Zarrabian will deliver his corporate presentation on October 12, 2021 at 2:00 p.m. PT / 5:00 p.m. ET.

Mr. Zarrabian will be available for one-on-one meetings throughout the conference.

Register to watch the presentation here.